Sepiapterin Decreases Vasorelaxation in Nitric Oxide Synthase Inhibition-Induced Hypertension

Journal of Cardiovascular Pharmacology

Volumn 43, Issue 1, 2004, Pages 93-98

  Mitchell, Brett M ^a   Dorrance, Anne M ^a   Ergul, Adviye ^b   Webb, R Clinton ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

Endothelium; GTP cyclohydrolase 1; Hypertension; Nitric oxide synthase; Tetrahydrobiopterin

Indexed keywords

ACETYLCHOLINE; ASCORBIC ACID; HYDROETHIDINE; N(G) NITROARGININE; NITRIC OXIDE SYNTHASE; SEPIAPTERIN; SUPEROXIDE DISMUTASE; TETRAHYDROBIOPTERIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOOXIDATION; BIOAVAILABILITY; BLOOD PRESSURE MEASUREMENT; COMPETITIVE INHIBITION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME INDUCTION; ENZYME INHIBITION; HYPERTENSION; MALE; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SYSTOLIC BLOOD PRESSURE;

ANIMALS; ANTIOXIDANTS; BIOPTERIN; ENDOTHELIUM, VASCULAR; HYPERTENSION; MALE; NITRIC OXIDE SYNTHASE; PTERINS; RATS; RATS, SPRAGUE-DAWLEY; VASODILATION;

EID: 0346333139     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200401000-00014     Document Type: Article

References (29)

1. Dominiczak AF, Bohr DF. Nitric oxide and its putative role in hypertension. Hypertension. 1995;25:1202-1211.
2. Kung CF, Moreau P, Takase H, et al. L-NAME hypertension alters endothelial and smooth muscle function in rat aorta: prevention by trandolapril and verapamil. Hypertension. 1995;26:744-748.
3. Shesely EG, Maeda N, Kim HS, et al. Elevated blood pressure in mice lacking endothelial nitric oxide synthase. Proc Natl Acad Sci. 1996;93:13176-13181.
4. Cosentino F, Barker JE, Brand MP, et al. Reactive oxygen species mediate endothelium-dependent relaxations in tetrahydrobiopterin-deficient mice. Arterioscler Thromb Vasc Biol. 2001;21:496-502.
5. Gross SS, Jones CL, Hattori Y, et al. Tetrahydrobiopterin: an essential cofactor of nitric oxide synthase with an elusive role. In: Ignarro L, ed. Nitric Oxide Biology and Pathobiology. San Diego, CA: Academic Press, 2000:167-186.
6. Vasquez-Vivar J, Kalyanaraman B, Martasek P, et al. Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc Natl Acad Sci. 1999;95:9220-9225.
7. Wever RMF, van Dam T, van Rijn HJM, et al. Tetrahydrobiopterin regulates superoxide and nitric oxide generation by recombinant endothelial nitric oxide synthase. Biochem Biophys Res Commun. 1997;237:340-344.
8. Xia Y, Tsai AL, Berka V, et al. Superoxide generation from endothelial nitric-oxide synthase. A clacium/calmodulin-dependent and tetrahydrobiopterin regulatory process. J Biol Chem. 1998;273:25804-25808.
9. Kojda G, Harrison DG. Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes, and heart failure. Cardiovasc Res. 1999;43:562-571.
10. Vasquez-Vivar J, Martasek P, Whitsett J, et al. The ratio between tetrahydrobiopterin and oxidized tetrahydrobiopterin analogues controls superoxide release from endothelial nitric oxide synthase: an EPR spin trapping study. Biochem J. 2002;362:733-739.
11. Shinozaki K, Kashiwagi A, Nishio Y, et al. Abnormal biopterin metabolism is a major cause of impaired endothelium-dependent relaxation through nitric oxide/O2-imbalance in insulin-resistant rat aorta. Diabetes. 1999;48:2437-2445.
12. Vasquez-Vivar J, Duquaine D, Whitsett J, et al. Altered tetrahydrobiopterin metabolism in atherosclerosis. Arterioscler Thromb Vasc Biol. 2002;22:1655-1661.
13. Cosentino F, Katusic ZS. Tetrahydrobiopterin and dysfunction of endothelial nitric oxide synthase in coronary arteries. Circulation. 1995;91:139-144.
14. Kinoshita H, Milstein S, Wambi C, et al. Inhibition of tetrahydrobiopterin biosynthesis impairs endothelium-dependent relaxations in canine basilar artery. Am J Physiol. 1997;273:H718-H724.
15. Tsutsui M, Milstein S, Katusic ZS. Effect of tetrahydrobiopterin on endothelial function in canine middle cerebral arteries. Circ Res. 1996;79:336-342.
16. Maier W, Cosentino F, Lutolf RB, et al. Tetrahydrobiopterin improves endothelial function in patients with coronary artery disease. J Cardiovasc Pharmacol. 2000;35:173-178.
17. Stroes E, Kastelein J, Cosentino F, et al. Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. J Clin Invest. 1997;99:41-46.
18. Tiefenbacher CP, Bleeke T, Vahl C, et al. Endothelial dysfunction of coronary resistance arteries is improved by tetrahydrobiopterin in atherosclerosis. Circulation. 2000;102:2172-2179.
19. Hong HJ, Hsiao G, Cheng TH, et al. Supplementation with tetrahydrobiopterin suppresses the development of hypertension in spontaneously hypertensive rats. Hypertension. 2001;38:1044-1048.
20. Vasquez-Vivar J, Whitsett J, Martasek P, et al. Reaction of tetrahydrobiopterin with superoxide: EPR-kinetic analysis and characterization of the pteridine radical. Free Radic Biol Med. 2001;31:975-985.
21. Huraux C, Makita T, Kurz S, et al. Superoxide production, risk factors, and endothelium-dependent relaxations in human internal mammary arteries. Circulation. 1999;99:53-59.
22. Yang D, Levens N, Zhang JN, et al. Specific potentiation of endothelium-dependent contractions in SHR by tetrahydrobiopterin. Hypertension. 2003;41:136-142.
23. Benov L, Sztejnberg L, Fridovich I. Critical evaluation of the use of hydroethidine as a measure of superoxide anion radical. Free Radic Biol Med. 1998;25:826-831.
24. Munzel T, Afanas'ev IB, Kleschyov AL, et al. Detection of superoxide in vascular tissue. Arterioscler Thromb Vasc Biol. 2002;22:1761-1768.
25. Baker TA, Milstien S, Katusic ZS. Effect of vitamin C on the availability of tetrahydrobiopterin in human endothelial cells. J Cardiovasc Pharmacol. 2001;37:333-338.
26. Heller R, Unbehaun A, Schellenberg B, et al. L-ascorbic acid potentiates endothelial nitric oxide synthesis via a chemical stabilization of tetrahydrobiopterin. J Biol Chem. 2001;276:40-47.
27. Huang A, Vita JA, Venema RC, et al. Ascorbic acid enhances endothelial nitric-oxide synthase activity by increasing intracellular tetrahydrobiopterin. J Biol Chem. 2000;275:17399-17406.
28. Amer MS. Possible involvement of the cyclic nucleotide system in hypertension. In: Weiss B, ed. Cyclic Nucletides in Disease. Baltimore: University Park Press, 1975:133-156.
29. Mitchell BM, Dorrance AM, Webb RC. GTP cyclohydrolase 1 down-regulation contributes to glucocorticoid hypertension in rats. Hypertension. 2003;41:669-674.